{"id":122205,"date":"2026-06-18T14:29:07","date_gmt":"2026-06-18T08:59:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=122205"},"modified":"2026-06-18T14:29:09","modified_gmt":"2026-06-18T08:59:09","slug":"cupid-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/","title":{"rendered":"Cupid Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Cupid share price target 2026 is Rs 200, implying approximately 20 percent upside from the current market price of Rs 164.89 (NSE: CUPID). With Q4 FY26 results released in 2026 and Contraceptives and Healthcare Products tailwinds in focus, the Rs 200 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/cupid\/cupid-ltd-share-price-today\">Cupid<\/a> (NSE: CUPID) is a Contraceptives and Healthcare Products company trading at Rs 164.89 with a market capitalisation of Rs 824 crore. Analysts have set the <strong>Cupid share price target<\/strong> at Rs 200 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Cupid_Share_Price_Target_2026_Key_Takeaways\" title=\"Cupid Share Price Target 2026: Key Takeaways\">Cupid Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Cupid_Company_Overview\" title=\"Cupid Company Overview\">Cupid Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Why_Is_the_Cupid_Share_Price_Target_Set_at_Rs_200_for_2026\" title=\"Why Is the Cupid Share Price Target Set at Rs 200 for 2026\">Why Is the Cupid Share Price Target Set at Rs 200 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Contraceptives_and_Healthcare_Products\" title=\"Structural Sector Tailwinds in Contraceptives and Healthcare Products\">Structural Sector Tailwinds in Contraceptives and Healthcare Products<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Cupid_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Cupid Share Price Targets: Short Term, 12 Month, and Long Term\">Cupid Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Short_Term_Cupid_Share_Price_Target\" title=\"Short Term Cupid Share Price Target\">Short Term Cupid Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#12-Month_Cupid_Share_Price_Target_2026\" title=\"12-Month Cupid Share Price Target 2026\">12-Month Cupid Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Long_Term_Cupid_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Cupid Share Price Target: FY27 to FY28\">Long Term Cupid Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Cupid_in_2026\" title=\"Bull Case and Bear Case Scenarios for Cupid in 2026\">Bull Case and Bear Case Scenarios for Cupid in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Bull_Case_Cupid_Share_Price_Target_Rs_240\" title=\"Bull Case Cupid Share Price Target: Rs 240\">Bull Case Cupid Share Price Target: Rs 240<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Bear_Case_Cupid_Share_Price_Target_Rs_130\" title=\"Bear Case Cupid Share Price Target: Rs 130\">Bear Case Cupid Share Price Target: Rs 130<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Cupid_2026_Price_Objective\" title=\"Key Risks That Could Derail the Cupid 2026 Price Objective\">Key Risks That Could Derail the Cupid 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Competitive_Intensity_Among_Contraceptives_and_Healthcare_Products_Peers\" title=\"Competitive Intensity Among Contraceptives and Healthcare Products Peers\">Competitive Intensity Among Contraceptives and Healthcare Products Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#How_to_Invest_in_Cupid\" title=\"How to Invest in Cupid\">How to Invest in Cupid<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#FAQs_on_Cupid_Share_Price_Target_2026\" title=\"FAQs on Cupid Share Price Target 2026\">FAQs on Cupid Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#What_is_the_Cupid_share_price_target_for_2026\" title=\"What is the Cupid share price target for 2026?\">What is the Cupid share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#What_was_the_Cupid_share_price_target_for_2025\" title=\"What was the Cupid share price target for 2025?\">What was the Cupid share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#Is_Cupid_a_good_investment_at_Rs_16489\" title=\"Is Cupid a good investment at Rs 164.89?\">Is Cupid a good investment at Rs 164.89?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#What_are_the_key_risks_to_the_Cupid_share_price_target_2026\" title=\"What are the key risks to the Cupid share price target 2026?\">What are the key risks to the Cupid share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Cupid\" title=\"What is the 52 week high and low of Cupid?\">What is the 52 week high and low of Cupid?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Cupid_in_2026\" title=\"What are the main growth catalysts for Cupid in 2026?\">What are the main growth catalysts for Cupid in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#How_does_Cupid_compare_to_its_peers\" title=\"How does Cupid compare to its peers?\">How does Cupid compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/cupid-share-price-target-2026\/#What_is_the_Cupid_share_price_target_for_2027\" title=\"What is the Cupid share price target for 2027?\">What is the Cupid share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Cupid_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Cupid Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Cupid share price target 2026:<\/strong> Rs 200 (20% upside from CMP Rs 164.89)<\/li>\n<li><strong>Bull case:<\/strong> Rs 240 | <strong>Bear case:<\/strong> Rs 130<\/li>\n<li><strong>Ticker:<\/strong> CUPID | <strong>Sector:<\/strong> Contraceptives and Healthcare Products | <strong>MCap:<\/strong> Rs 824 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 114 to Rs 270 | <strong>PE:<\/strong> 20x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Cupid_Company_Overview\"><\/span><strong>Cupid Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cupid (NSE: CUPID) is a Nashik-based WHO pre-qualified manufacturer of male condoms, female condoms, and lubricants supplying to UNFPA, government health programs, and retail pharmacy chains across India and 30-plus countries. At CMP Rs 164.89 against a 52 week range of Rs 114 to Rs 270, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 824 crore with trailing PE of 20x. Compared to peers in healthcare products like HLL Lifecare and Mankind Pharma, Cupid is positioned as a potential re-rating candidate toward the Rs 200 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>CUPID<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Contraceptives and Healthcare Products<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 164.89<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 270<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 114<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 824 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>20x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 200<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 240<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 130<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Cupid_Share_Price_Target_Set_at_Rs_200_for_2026\"><\/span><strong>Why Is the Cupid Share Price Target Set at Rs 200 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Cupid share price target<\/strong> of Rs 200 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 164.89. The Rs 200 price objective represents the base case with FY27 execution as the key variable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Contraceptives_and_Healthcare_Products\"><\/span><strong>Structural Sector Tailwinds in Contraceptives and Healthcare Products<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Contraceptives and Healthcare Products sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Cupid&#8217;s market position among peers in healthcare products like HLL Lifecare and Mankind Pharma creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 240 bull case to materialise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Cupid&#8217;s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 200 analyst consensus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable policy backdrop for Cupid&#8217;s Contraceptives and Healthcare Products operations, improving the probability of achieving the FY27 earnings targets that support the Rs 200 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 20x PE, Cupid is positioned as a beneficiary of institutional reallocation, providing a tailwind toward the Rs 240 bull case over the medium term.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cupid_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Cupid Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Cupid_Share_Price_Target\"><\/span><strong>Short Term Cupid Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Cupid is anchored close to the 52 week low of Rs 114. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors can use the 52 week low as an entry reference while awaiting FY27 earnings confirmation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Cupid_Share_Price_Target_2026\"><\/span><strong>12-Month Cupid Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Cupid share price target 2026<\/strong> is Rs 200, implying approximately 20 percent upside from CMP Rs 164.89. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Track live on NSE ticker CUPID.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Cupid_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Cupid Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Cupid share price target<\/strong> for FY27 to FY28 is Rs 240 in the bull case, requiring full earnings delivery, re-rating among peers in healthcare products like HLL Lifecare and Mankind Pharma, and sustained institutional buying over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Cupid_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Cupid in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Cupid_Share_Price_Target_Rs_240\"><\/span><strong>Bull Case Cupid Share Price Target: Rs 240<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Cupid share price target<\/strong> of Rs 240 materialises when FY27 earnings beat analyst estimates, Contraceptives and Healthcare Products tailwinds accelerate, and FII flows return strongly to Indian equities, enabling re-rating toward higher peer multiples. From CMP Rs 164.89, this represents approximately 45 percent potential upside.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Cupid_Share_Price_Target_Rs_130\"><\/span><strong>Bear Case Cupid Share Price Target: Rs 130<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Cupid share price target<\/strong> of Rs 130 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of the 52 week low support near Rs 114.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 240<\/td>\n<td>FY27 beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 200<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 130<\/td>\n<td>FY27 miss, guidance cut, FII outflows<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Cupid_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Cupid 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the <strong>Cupid share price target<\/strong> of Rs 200, with FII outflows being the direct transmission mechanism to Indian equity valuations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress valuation multiples. This is the most direct company-specific risk to the Rs 200 analyst price objective. Investors must monitor quarterly results and management commentary closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Contraceptives_and_Healthcare_Products_Peers\"><\/span><strong>Competitive Intensity Among Contraceptives and Healthcare Products Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in healthcare products like HLL Lifecare and Mankind Pharma could compress Cupid&#8217;s market share and pricing power. This structural risk must be weighed when assessing the defensibility of the earnings trajectory that underpins the Rs 200 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should size positions carefully and maintain stop losses to protect capital if broad market de-rating continues.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Cupid\"><\/span><strong>How to Invest in Cupid<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Cupid share price target<\/strong> of Rs 200, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Contraceptives and Healthcare Products sector demand and competition.<\/p>\n<p>Open a Demat account with a SEBI registered stockbroker to trade Cupid (NSE: CUPID) with regulatory protection. Study the competitive landscape among peers in healthcare products like HLL Lifecare and Mankind Pharma before executing any position.<\/p>\n<p>Plan your entry using the 52 week low of Rs 114 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 200 price target. Always set a stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the Contraceptives and Healthcare Products space where sectoral cycles can amplify volatility beyond initial expectations.<\/p>\n<p>Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Cupid&#8217;s live share price and receive daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Cupid_Share_Price_Target_2026\"><\/span><strong>FAQs on Cupid Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Cupid_share_price_target_for_2026\"><\/span><strong>What is the Cupid share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Cupid share price target 2026 is Rs 200, implying approximately 20 percent upside from CMP Rs 164.89. Bull case is Rs 240, bear case is Rs 130.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Cupid_share_price_target_for_2025\"><\/span><strong>What was the Cupid share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Cupid was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 200, reflecting FY27 growth potential from CMP Rs 164.89.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Cupid_a_good_investment_at_Rs_16489\"><\/span><strong>Is Cupid a good investment at Rs 164.89?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 164.89, Cupid offers potential upside toward Rs 200 if FY27 earnings recover. Consult a SEBI registered financial advisor before investing based on any price target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Cupid_share_price_target_2026\"><\/span><strong>What are the key risks to the Cupid share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Cupid share price target of Rs 200 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Contraceptives and Healthcare Products. Monitoring quarterly results is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Cupid\"><\/span><strong>What is the 52 week high and low of Cupid?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Cupid is Rs 270 and the 52 week low is Rs 114. At CMP Rs 164.89, the stock is below its 52 week high and offers upside toward the Rs 200 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Cupid_in_2026\"><\/span><strong>What are the main growth catalysts for Cupid in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key catalysts include FY27 PAT recovery, Contraceptives and Healthcare Products tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Cupid_compare_to_its_peers\"><\/span><strong>How does Cupid compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cupid operates in Contraceptives and Healthcare Products alongside peers in healthcare products like HLL Lifecare and Mankind Pharma. At CMP Rs 164.89 with MCap Rs 824 crore, it is a potential re-rating candidate toward the Cupid share price target of Rs 200 on FY27 delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Cupid_share_price_target_for_2027\"><\/span><strong>What is the Cupid share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Cupid share price target for FY27 to FY28 is Rs 240 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Cupid share price target 2026 is Rs 200, ~20% upside from CMP Rs 164.89. Bull Rs 240, bear Rs 130. 2026.<\/p>\n","protected":false},"author":35,"featured_media":122581,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-122205","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781773180:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["82"],"rank_math_title":["Cupid Share Price Target 2026: Rs 200 Analyst Forecast"],"rank_math_description":["The Cupid share price target 2026 is Rs 200, ~20% upside from CMP Rs 164.89. Bull Rs 240, bear Rs 130. 2026."],"rank_math_focus_keyword":["Cupid share price target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["122581"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["19122"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Cupid-Share-Price-Target-2026-Analyst-Forecast-Bull-and-Bear-Case.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/122205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=122205"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/122205\/revisions"}],"predecessor-version":[{"id":122582,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/122205\/revisions\/122582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/122581"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=122205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=122205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=122205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}